The rules regarding TUEs for IVs make it clear that Floyd should not have been allowed to have this infusion. Read the WADA Code below. It specifically talks about sports with weight classifications abusing IVs.
"Intravenous Infusions and/or Injections
1. Introduction
Intravenous (IV) infusions have been included on the WADA List of Prohibited
Substances and Methods under section M2. Prohibited Methods, Chemical and
Physical Manipulation since 2005. They are prohibited both in- and out-ofcompetition.
The current wording in the 2015 Prohibited List states that Intravenous infusions
and/or injections of more than 50 mL per 6 hour period are prohibited except for those
legitimately received in the course of hospital admissions, surgical procedures or clinical
investigations (1).
The wording in the Prohibited List for IV infusions is unique in that the method is
not prohibited under the three exceptions as stated above. However, even if
there may be no requirement for a TUE for the intravenous infusion as a
method, for any prohibited substance (whether in- or out-of-competition) that is
administered via IV infusion, a TUE must be requested for the Prohibited
Substance.
IV infusions are included on the Prohibited List mainly because some athletes
could use this Prohibited Method to:
a) increase their plasma volume levels;
b) mask the use of a Prohibited Substance;
c) distort the values of their Athlete Biological Passport.
In sports with weight classifications, athletes may be encouraged to undertake
significant, accelerated weight loss to qualify for a competition and then use IV
infusion to rapidly rehydrate. This practice invokes issues of athlete health and
safety.
An IV infusion or injection is the supply of fluid and/or prescribed medication by
means of a syringe or “butterfly” needle, directly into a vein.
Infusions or injections of 50 mL or less per a 6-hour period are permitted unless
the infused/injected substance is on the Prohibited List.
Infusions or injections of more than 50 mL per a 6-hour period are prohibited
unless the infused/injected substance is administered during a hospital
admission, surgical procedure or clinical investigation. Please consult the tables/
TUE Physician Guidelines
Medical Information to Support the Decisions of TUECs
INTRAVENOUS INFUSIONS
© WADA - World Anti-Doping Program
Version 4.0
February 2015
2
figures in the Appendix for more details on the principles and examples of when
IV infusion/injections of certain substances are permitted or prohibited.
If a non-prohibited substance is infused or injected without a concurrent hospital
admission, surgical procedure or clinical investigation; a TUE must be submitted
for this Prohibited Method if more than 50 mL of fluid per a 6-hour period is
infused or injected.
If a Prohibited Substance is administered via IV infusion or injection a TUE
application must be submitted for the Prohibited Substance regardless of
whether the infusion is less than 50 mL or the setting/circumstances under
which it is administered. In situations of medical emergency or clinical time
constraints, a retroactive TUE application is acceptable (ISTUE 2015 article 4.3).
2. Diagnosis
A. Medical history
A summary of the athlete’s history and the findings of a physical
examination should confirm the diagnosis and establish the need for an IV
infusion. A precise description of the clinical situation and specific medical
indication for the IV infusion must be given in the TUE application.
Note that if an IV infusion or injection is part of a clinical investigation,
surgical procedure or hospital admission, there is no requirement for a
TUE. The athlete is nevertheless advised to obtain and keep a copy of the
medical records from the intervention or procedure.
B. Diagnostic criteria
A clearly defined diagnosis should be established in accordance with the
International Classification of Diseases standards of the World Health
Organization ICD-10).
C. Relevant medical information
A detailed description of the substance to be infused, the rate of infusion
and any other relevant clinical information from the treating physician
should be included. It must be demonstrated why an alternative permitted
therapy, for example oral rehydration in case of dehydration, is not a valid
option. Any existing co-morbidities that would influence the decision for
granting a TUE should also be included.
TUE Physician Guidelines
Medical Information to Support the Decisions of TUECs
INTRAVENOUS INFUSIONS
© WADA - World Anti-Doping Program
Version 4.0
February 2015
3
3. Medical best practice treatment
Legitimate medical indications for IV infusions are well documented and are
most commonly associated with either medical emergencies or in-patient care.
When an IV infusion is administered to an athlete, the following criteria should
be fulfilled:
1. A clearly defined diagnosis.
2. Supportive evidence that no permitted alternative treatment can be
used.
3. The treatment has been ordered by a physician and administered by
qualified medical personnel in an appropriate medical setting.
4. Adequate medical records of the treatment.
The use of IV infusions in sport is commonly linked with rehydration after
exhaustive effort, and this situation is arguably the major cause of debate. It
must be understood that the use of IV fluid replacement following exercise to
correct mild to moderate dehydration is not clinically indicated nor substantiated
by the medical literature. There is a well-established body of scientific evidence
to confirm that oral rehydration is the preferred therapeutic choice, potentially
even more effective than IV infusion.
(Ref: 3, 4, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
A. Name of Prohibited Method
IV infusion or injection of >50 mL per a 6 hour period unless legitimately
received in the course of hospital admissions, surgical procedures or
clinical investigations.
B. Recommended Duration
Dependent on diagnosis and on the particular clinical situation, but if the
infusion is a single intervention, the TUE should be valid for a relatively
short duration.
4. Other non-prohibited alternative treatments
Oral rehydration or oral delivery of medication.
5. Consequences to health if treatment withheld
These will be dependent on the clinical situation. However, in case of a medical
emergency, a possible consequence of withholding treatment could result in
serious harm to the health or even death. Therefore, the health and well-being
of the athlete must always remain the priority.
TUE Physician Guidelines
Medical Information to Support the Decisions of TUECs
INTRAVENOUS INFUSIONS
© WADA - World Anti-Doping Program
Version 4.0
February 2015
4
6. Treatment monitoring
Continuous evaluation by treating physician or someone acting on his/her behalf
until the desired treatment effect has been achieved.
7. TUE validity and recommended review process
The duration of the TUE is usually for a short time period surrounding the initial
medical intervention. Longer usage of an IV infusion would typically occur in a
hospital setting and therefore does not require a TUE.
8. Any appropriate cautionary matters
It is the responsibility of the treating physician to evaluate the clinical indication
for an IV infusion or injection and the subsequent need for a TUE application.
At all times, the health and well-being of the athlete must remain the priority
during medical investigations and treatments. TUECs should apply sound clinical
judgment to their interpretation of the ISTUE, but be mindful of the
inappropriate use of IV infusion in non-emergency situations wh